• 1. Inorganic chemistry
  J. Chem. Soc. Abstr. 1923 124 ii403
• 2. Inorganic chemistry
  J. Chem. Soc. Abstr. 1912 102 ii933
• 3. Organic chemistry
  J. Chem. Soc. Abstr. 1904 86 A133
• 4. Index of author's names
  J. Chem. Soc. Abstr. 1923 124 ii893
• 5. Bibliography on the analytical applications of ion-exchange resins
  G. H. Osborn Analyst 1953 78 221

Recent Advances in Chromium (III) Sulphate Basic (39380-78-4) Research: Applications and Innovations in Chemical Biomedicine

Chromium (III) sulphate basic (CAS: 39380-78-4) has garnered significant attention in the field of chemical biomedicine due to its unique properties and potential applications. Recent studies have explored its role in various biomedical and industrial processes, including its use as a tanning agent, catalyst, and potential therapeutic agent. This research brief aims to synthesize the latest findings on chromium (III) sulphate basic, focusing on its chemical properties, applications, and emerging trends in the field.

One of the key areas of research involves the compound's role in leather tanning, where it is valued for its ability to produce high-quality leather with enhanced durability and resistance to degradation. Recent advancements have focused on optimizing the tanning process to reduce environmental impact while maintaining product quality. Studies have also investigated the compound's catalytic properties, particularly in organic synthesis, where it has shown promise in facilitating various chemical reactions under mild conditions.

In the biomedical realm, chromium (III) sulphate basic has been explored for its potential therapeutic effects, particularly in the context of chromium supplementation for metabolic disorders. Research has indicated that chromium (III) compounds may play a role in improving insulin sensitivity and glucose metabolism, although the mechanisms remain under investigation. Recent clinical trials have sought to elucidate these effects further, with some studies reporting positive outcomes in patients with type 2 diabetes.

Another notable area of research is the compound's application in wastewater treatment. Chromium (III) sulphate basic has been utilized as a coagulant to remove heavy metals and other contaminants from industrial effluents. Recent studies have focused on enhancing its efficiency and sustainability, with innovations such as hybrid coagulation-flocculation processes showing promising results. These developments highlight the compound's versatility and potential for addressing environmental challenges.

Despite these advancements, challenges remain, particularly concerning the safety and environmental impact of chromium (III) sulphate basic. Recent research has emphasized the need for rigorous toxicity assessments and the development of greener alternatives. For instance, studies have explored the use of biodegradable ligands to reduce the environmental footprint of chromium-based processes. These efforts underscore the importance of balancing industrial and biomedical applications with sustainability considerations.

In conclusion, chromium (III) sulphate basic (39380-78-4) continues to be a compound of significant interest in chemical biomedicine, with diverse applications ranging from industrial processes to potential therapeutic uses. Ongoing research aims to optimize its properties, expand its applications, and address associated challenges. As the field evolves, further studies will be essential to fully harness the potential of this versatile compound while ensuring its safe and sustainable use.

• 13465-61-7(discandium trisulphate)
• 10141-00-1(ALUM CHROME)
• 14489-25-9(Sulfuric acid, chromiumsalt (8CI,9CI))
• 10022-47-6(Ammonium chromium(III)sulfate dodecahydrate)
• 17854-98-7(Sulfuric acid,chromium(3+) sodium salt (2:1:1), dodecahydrate (8CI,9CI))
• 33849-58-0(Sulfuric acid,scandium(3+) salt (3:2), hydrate (8CI,9CI))
• 12336-95-7(basic chromic sulfate)
• 15005-90-0(Sulfuric acid,chromium(3+) salt (3:2), hexahydrate (8CI,9CI))
• 15292-44-1(Sulfuric acid,scandium(3+) salt (3:2), pentahydrate (8CI,9CI))
• 10031-37-5(Chromium(III) sulfate hydrate)